Site icon OncologyTube

Yasmin Abaza, MD- AML and MDS: Challenges and Future Directions

Yasmin Abaza, MD Assistant Professor, Medicine (Hematology and Oncology)

In a captivating interview, Yasmin Abaza, MD, an esteemed Assistant Professor of Medicine at Northwestern University, delved into her research focus on Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS). Offering a comprehensive overview of immune cell therapies for these conditions, Dr. Abaza touched upon the historical struggles encountered in achieving successful outcomes. She candidly highlighted the limited success observed thus far while shedding light on the promising agents currently undergoing clinical trials.

REGISTER NOW TO JOIN US AT THESE UPCOMING EVENTS
AML-ALL US – Online content available – https://aml-allus2023.md-education.com/register/
AML-ALL EU – Registration open – https://aml-alleu2023.md-education.com/register/
MPN-MDS EU – registration open – https://mpn-mdseu2023.md-education.com/register/
Register – AML-ALL US Focus Meeting 2023
aml-allus2023.md-education.com

During the discussion, Yasmin Abaza, MD expressed optimism about the future of immunotherapies for AML and MDS. She conveyed her appreciation for the collective intellect showcased at the event, acknowledging the stimulating atmosphere and diverse range of topics covered. Dr. Abaza’s insights provided a valuable perspective on the challenges faced in the realm of immune cell therapies and emphasized the collaborative efforts required to pave the way for improved treatments in these critical medical domains.

Advertisement
Exit mobile version